gnw-20260820
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________________________________
FORM 8-K
___________________________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
August 20, 2026
Date of Report
(Date of earliest event reported)
___________________________________________________________
GENWORTH FINANCIAL, INC.
(Exact name of registrant as specified in its charter)
___________________________________________________________
Delaware | 001-32195 | 80-0873306 | ||||||||||||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
11011 West Broad Street, Glen Allen, Virginia | 23060 | |||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
(804) 281-6000
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
___________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
| Common Stock, par value $.001 per share | GNW | New York Stock Exchange | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 20, 2026, Genworth Financial, Inc. (the “Company”) announced that Thomas J. McInerney will return from a leave of absence and resume the role of President & Chief Executive Officer, effective September 2, 2026. In connection with Mr. McInerney’s return, he will resume day-to-day operational responsibilities and the role of principal executive officer of the Company.
Accordingly, Jerome T. Upton, who has been serving as the Company’s Interim President and Chief Executive Officer (Principal Executive Officer), will no longer serve in that capacity as of September 2, 2026, and will continue to serve in his current role as the Company’s Executive Vice President and Chief Financial Officer (Principal Financial Officer).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GENWORTH FINANCIAL, INC. | |||||||||||
| Date: August 20, 2026 | By: | /s/ Michael J. McCullough | |||||||||
| Michael J. McCullough | |||||||||||
| Senior Vice President and Corporate Secretary | |||||||||||